These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1898891

  • 1. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.
    Sagle MA, Hamilton-Fairley D, Kiddy DS, Franks S.
    Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891
    [Abstract] [Full Text] [Related]

  • 2. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome.
    Larsen T, Larsen JF, Schiøler V, Bostofte E, Felding C.
    Fertil Steril; 1990 Mar; 53(3):426-31. PubMed ID: 2106449
    [Abstract] [Full Text] [Related]

  • 3. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO, Tanbo T, Haug E, Abyholm T.
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [Abstract] [Full Text] [Related]

  • 4. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S, Paradisi R, Fabbri R, Porcu E, Orsini LF, Flamigni C.
    Int J Fertil; 1987 Sep; 32(1):66-70. PubMed ID: 2880819
    [Abstract] [Full Text] [Related]

  • 5. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y, Yamada H, Yoshida K, Manno T, Ubukata Y, Suzuki M, Yoshimura Y.
    Horm Res; 1990 Sep; 33 Suppl 2():43-8. PubMed ID: 2128881
    [Abstract] [Full Text] [Related]

  • 6. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin.
    McFaul PB, Traub AI, Thompson W.
    Fertil Steril; 1990 May; 53(5):792-7. PubMed ID: 2110070
    [Abstract] [Full Text] [Related]

  • 7. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.
    Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
    [Abstract] [Full Text] [Related]

  • 8. A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.
    Balasch J, Fábregues F, Casamitjana R, Peñarrubia J, Vanrell JA.
    Reprod Biomed Online; 2003 Oct; 6(3):296-301. PubMed ID: 12735863
    [Abstract] [Full Text] [Related]

  • 9. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS, Nahuis M, Bayram N, Mol BW, Van der Veen F, van Wely M.
    Cochrane Database Syst Rev; 2015 Sep 09; (9):CD010290. PubMed ID: 26350625
    [Abstract] [Full Text] [Related]

  • 10. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
    Fulghesu AM, Lanzone A, Guida C, Nicoletti MC, Rossi P, Le Donne M, Caruso A, Mancuso S.
    J Reprod Med; 1992 Oct 09; 37(10):834-40. PubMed ID: 1479563
    [Abstract] [Full Text] [Related]

  • 11. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
    van Weissenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J.
    Hum Reprod; 1993 Jun 09; 8(6):813-21. PubMed ID: 8345068
    [Abstract] [Full Text] [Related]

  • 12. The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
    Raj SG, Berger MJ, Grimes EM, Taymor ML.
    Fertil Steril; 1977 Dec 09; 28(12):1280-4. PubMed ID: 590534
    [Abstract] [Full Text] [Related]

  • 13. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome.
    Homburg R, Levy T, Berkovitz D, Farchi J, Feldberg D, Ashkenazi J, Ben-Rafael Z.
    Fertil Steril; 1993 Mar 09; 59(3):527-31. PubMed ID: 8458452
    [Abstract] [Full Text] [Related]

  • 14. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease.
    Abdel Gadir A, Mowafi RS, Alnaser HM, Alrashid AH, Alonezi OM, Shaw RW.
    Clin Endocrinol (Oxf); 1990 Nov 09; 33(5):585-92. PubMed ID: 2123759
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
    Li C, Cheng J, Wang J, Xue Y, Huang Z, Zhang S, Lv J.
    Arch Gynecol Obstet; 2011 Sep 09; 284(3):757-64. PubMed ID: 21614496
    [Abstract] [Full Text] [Related]

  • 16. Premature luteinization and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome.
    McFaul PB, Traub AI, Thompson W.
    Acta Eur Fertil; 1989 Sep 09; 20(3):157-61. PubMed ID: 2516391
    [Abstract] [Full Text] [Related]

  • 17. Continuous subcutaneous infusion of human menopausal gonadotropin in anovulatory women with decreased FSH/LH ratio and androgen excess.
    Kuroda G, Yano K, Suginami H.
    Endocrinol Jpn; 1988 Feb 09; 35(1):27-37. PubMed ID: 3135179
    [Abstract] [Full Text] [Related]

  • 18. [Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
    Uemura T, Yoshimura Y, Ishikawa M, Asukai K, Minaguchi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul 09; 41(7):923-6. PubMed ID: 2507714
    [No Abstract] [Full Text] [Related]

  • 19. A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome.
    Anderson RE, Cragun JM, Chang RJ, Stanczyk FZ, Lobo RA.
    Fertil Steril; 1989 Aug 09; 52(2):216-20. PubMed ID: 2502437
    [Abstract] [Full Text] [Related]

  • 20. Similar pregnancy and spontaneous abortion rates after treatment with low-dose human menopausal gonadotropin versus pure follicle stimulating hormone in women with luteal phase defects.
    Check JH, Fine W.
    Clin Exp Obstet Gynecol; 1997 Aug 09; 24(1):5-7. PubMed ID: 9107444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.